Barbadillo, Vennieclaire .
HRN: 19-26-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2025
CEFUROXIME 500MG (TAB)
02/27/2025
03/06/2025
PO
500mg
BID
S/P CS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes